Guest Editorial The National Highway Traffic Safety Administration has a profound, albeit not immediately obvious, impact on cancer February 06, 2026Vol.52 No.05By Ken Kobayashi and Joan H. Schiller
PodcastThe Directors The Directors: Gary Schwartz and Ramon Parsons on the best of times (for science), the worst of times (for funding)Cancer centers fund small grants to boost morale amid low paylines January 30, 2026Vol.52 No.04By Paul Goldberg and Claire Marie Porter
Capitol Hill FY26 funding package blocked in Senate after ICE shooting of Alex PrettiNew package—likely excluding DHS—may go back to House early next week January 30, 2026Vol.52 No.04By Jacquelyn Cobb
FreeObituary Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42 January 30, 2026Vol.52 No.04
FreeTrials & Tribulations Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore January 30, 2026Vol.52 No.04By Les Biller
Sponsored Antibody halts triple-negative breast cancer in preclinical models January 30, 2026Vol.52 No.04By Hayley Kamin
Premarin’s 84-year hold on the market ends as FDA approves a generic versionTrade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer January 23, 2026Vol.52 No.03By Claire Marie Porter
Capitol Hill Spending bill passed by the House gives NIH $415M raise, NCI gets $128MLegislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched January 23, 2026Vol.52 No.03By Jacquelyn Cobb
Capitol Hill Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill January 23, 2026Vol.52 No.03By Jacquelyn Cobb
Guest Editorial Blood Cancer United: A new name at the right moment January 23, 2026Vol.52 No.03By E. Anders Kolb
